Dyne Therapeutics (DYN) PT Raised to $31 at Chardan Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $15.44 +1.58%
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 35
Rating Summary:
17 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 35
Join SI Premium – FREE
Chardan Capital Markets analyst Keay Nakae raised the price target on Dyne Therapeutics (NASDAQ: DYN) to $31.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Dyne Therapeutics (DYN) PT Lowered to $32 at H.C. Wainwright
- Dyne Therapeutics (DYN) Reiterated at Overweight by Cantor Fitzgerald on Ph1/2 Data Release
- Ultra Clean (UCTT) PT Lowered to $135 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
